RATIONALE: Selective hypersensitivity reactions (SHR) are the second most frequent NSAID-induced hypersensitivity. Our aim was to characterize a group of patients with SHR to NSAIDs, analyzing symptoms, culprit drugs and diagnostic methods. METHODS: We verified acetylsalicylic acid (ASA)-tolerance and classified patients as single NSAID-induced urticaria/angioedema/anaphylaxis (SNIUAA) or single-NSAID-induced delayed hypersensitivity reactions (SNIDHR) whether the symptoms appeared less or more than 24 hours after NSAIDs administration. In metamizole-induced-SNIUAA, we performed skin tests (STs), and if negative basophil activation test (BAT) was performed. When these tests were or other drugs were involved with <2 episodes reported, drug provocation test (DPT) with the culprit was performed. RESULTS: We included 518 patients with a mean age of 43 (31.25-54) years, 459 SNIUAA and 59 SNIDHR, and 66.2% were female. In SNIUAA, anaphylaxis (32.4%) was the most frequent entity, and in SNIDHR was maculopapular exanthema (44.1% Nevertheless, most studies use monocyte-derived dendritic cells (moDCs) instead of myeloid DCs (mDCs) because of the low number of the later in blood. Although this approximation is well-validated, moDCs could be more similar to monocyte than from DCs. Therefore, the main objective of this study was to analyze the maturation and activation differences between moDCs and mDCs during the recognition of two betalactams, amoxicillin (AX) and clavulanic acid (CLV). METHODS: mDCs and monocytes were isolated from peripheral blood mononuclear cells from allergic patients with selective immediate reaction to AX (N510) or CLV (N510) and controls (N510). To obtain moDCs, monocytes were cultured with GM-CSF and IL-4. moDCs and mDCs were cultured with the culprit drug. Expression of CCR7, CD40, CD80, CD83 and CD86 markers were analyzed by flow cytometry and represented as maturation index (MI). RESULTS: Higher expression of maturation and activation markers were found in allergic patients compared to controls. Higher MI of CCR7, CD40 and CD86 were found in mDCs compared with moDCs in AX allergic patients (p50.006, p50.02, p50.02, respectively). Likewise, higher MI of CCR7 (p50.04) and CD40 (p50.01) were found in mDCs from CLV allergic patients. No differences were found for CD80 and CD83 expression. CONCLUSIONS: The analysis of maturation and activation in mDCs showed higher MI levels suggesting that the use of these cells could represent a more realistic and accurate approximation to the biological process. 
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